Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions-Reference-Cited by-同舟云学术

Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions

Published:2013-04-14 Issue:5 Volume:19 Page:614-618
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

De Sousa E Melo Felipe,Wang Xin,Jansen Marnix,Fessler Evelyn,Trinh Anne,de Rooij Laura P M H,de Jong Joan H,de Boer Onno J,van Leersum Ronald,Bijlsma Maarten F,Rodermond Hans,van der Heijden Maartje,van Noesel Carel J M,Tuynman Jurriaan B,Dekker Evelien,Markowetz Florian,Medema Jan Paul,Vermeulen Louis

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm.3174.pdf

Reference47 articles.

1. Wolpin, B.M. & Mayer, R.J. Systemic treatment of colorectal cancer. Gastroenterology 134, 1296–1310 (2008).

2. Markowitz, S.D. & Bertagnolli, M.M. Molecular origins of cancer: Molecular basis of colorectal cancer. N. Engl. J. Med. 361, 2449–2460 (2009).

3. Verhaak, R.G. et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17, 98–110 (2010).

4. Barretina, J. et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483, 603–607 (2012).

5. Julien, S. et al. Characterization of a large panel of patient-derived tumor xenografts representing the clinical heterogeneity of human colorectal cancer. Clin. Cancer Res. 18, 5314–5328 (2012).

Cited by 652 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrating bulk RNA-seq and scRNA-seq analyses revealed the function and clinical value of thrombospondins in colon cancer;Computational and Structural Biotechnology Journal;2024-12

2. Inhibiting S-palmitoylation arrests metastasis by relocating Rap2b from plasma membrane in colorectal cancer;Cell Death & Disease;2024-09-14

3. Evaluation of the Use of Cell Lines in Studies of Selenium-Dependent Glutathione Peroxidase 2 (GPX2) Involvement in Colorectal Cancer;Diseases;2024-09-10

4. Consensus molecular subtyping of metastatic colorectal cancer expands biomarker-directed therapeutic benefit for patients with CMS1 and CMS2 tumors;British Journal of Cancer;2024-09-04

5. Transcriptomic subtyping of gastrointestinal malignancies;Trends in Cancer;2024-09